No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LBPH240719P25000
- 1.72
- +0.02+1.18%
15min DelayClose Jun 28 15:59 ET
1.72High1.70Low
1.70Open1.70Pre Close52 Volume0 Open Interest25.00Strike Price8.84KTurnover120.77%IV13.87%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry1.72Extrinsic Value100Contract SizeAmericanOptions Type-0.3353Delta0.0471Gamma13.35Leverage Ratio-0.0681Theta-0.0057Rho-4.48Eff Leverage0.0234Vega
Intraday
- 5D
- Daily
News
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Express News | Longboard Pharmaceuticals Inc : Evercore ISI Raises Target Price to $57 From $44
Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target
Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $60 price target.
Evercore ISI Raises Price Target on Longboard Pharmaceuticals to $57 From $44, Maintains Outperform Rating
Longboard Pharmaceuticals (LBPH) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $32 to $60.
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities